Raymond James analyst Justin Jenkins maintains ONEOK (NYSE:OKE) with a Outperform and raises the price target from $65 to $72.
Analyst Expectations for Mesoblast’s Future
Analysts have provided the following ratings for Mesoblast (NASDAQ:MESO) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…